Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kagan Atikeler"'
Autor:
Marcin Czech, Aleksandra Baran-Kooiker, Kagan Atikeler, Maria Demirtshyan, Kamilla Gaitova, Malwina Holownia-Voloskova, Adina Turcu-Stiolica, Coen Kooiker, Oresta Piniazhko, Natella Konstandyan, Olha Zalis'ka, Jolanta Sykut-Cegielska
Publikováno v:
Frontiers in Public Health, Vol 7 (2020)
Background: Despite international initiatives on collaboration within the field of rare diseases, patient access to orphan medicinal products (OMPs) and healthcare services differ greatly between countries. This study aimed to create a comprehensive
Externí odkaz:
https://doaj.org/article/54fbf934650d4dfaa00a5bc3825e3426
Autor:
Guvenc Kockaya, Kagan Atikeler, Esin Tuna, Pelin Kılıc, Pelin Tanyeri, Nurcan Umman, İsmail Mert Vural, Omer Altun, Akif Akbulat, Guven Artiran, Ercan Simsek, Hakkı Gursoz, Saim Kerman
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 14, Iss 2, Pp 99-103 (2013)
OBJECTIVES: General Directorate of Pharmaceuticals and Pharmacy (IEGM) is responsible for setting all prices for human medicinal products. The reference pricing system is used for setting these prices. Reference countries are reviewed annually and ma
Externí odkaz:
https://doaj.org/article/9f6d1406e87e43f8847456784b07372f
Autor:
Guven Bektemur, Esra Safak Yilmaz, Elif Hilal Vural, Enver Kagan Atikeler, Banu Bayar, Hakki Gursoz
Publikováno v:
Medicine Science, Vol 7, Iss 3, Pp 684-90 (2018)
There have been many developments that affected the Turkish pharmaceutical market following the Health Transformation Program (2003) and Social Security Reform (2006). The objective of this study was to investigate effects of the developments in Turk
Externí odkaz:
https://doaj.org/article/fd40e6bc05db419da63f5f37ca024177
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:16-17
IntroductionTurkey's health reforms, which started in 2003, have led to increased access to health care and pharmaceuticals as well as rising public pharmaceutical expenditures. The need to improve healthcare decision making by implementing health te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2339ade362dd3837fcc895d15616fa96
https://doi.org/10.1017/s0266462320001282
https://doi.org/10.1017/s0266462320001282
Autor:
Enver Kagan Atikeler, Simten Malhan, Hakkı Gürsöz, Elif Hilal Vural, Engin Doğan, Nurgül Karabekmez, Çiğdem Tolun, Hakan Eroğlu, Banu Bayar, Güven Bektemür, I.M. Vural, Salih Babacan, Aslıhan Beyan, Ali Alkan, Rabia Kahveci, Ipek Kivilcim Oguzulgen, Sedat Altın, Esra Safak Yilmaz, Nurcan Uman Kutkan
Publikováno v:
Value in health regional issues. 13
Background With the rise in life expectancy, the burden of chronic diseases, including obstructive pulmonary diseases, has increased throughout the world. Objectives To evaluate the sales trends of inhaler pharmaceuticals. Methods The changes in box
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c4b45ec502386344211ed611b544e8
https://pubmed.ncbi.nlm.nih.gov/29073985
https://pubmed.ncbi.nlm.nih.gov/29073985
Autor:
Enver Kagan Atikeler, Gülbin Özçelikay
Publikováno v:
SpringerPlus
Recently, the need for health care services has increased gradually and the limitations in sources allocated for this area have been recognized. Moving from this fact, it has gained a supreme importance to determine what health programs or technologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::558a03ab3f68860fd6ab1143d73c0998
https://pubmed.ncbi.nlm.nih.gov/27833835
https://pubmed.ncbi.nlm.nih.gov/27833835